Holen Sie sich die Stockscreener-App
0.00
100.00%
-4.36
Adverum Biotechnologies Inc Aktie (ADVM) Neueste Nachrichten
Levels Update: Is Adverum Biotechnologies Inc gaining market shareMarket Sentiment Summary & Advanced Technical Signal Analysis - baoquankhu1.vn
Is Adverum Biotechnologies Inc. gaining market share2025 Valuation Update & Safe Capital Growth Plans - mfd.ru
Will Adverum Biotechnologies Inc. announce a stock splitWeekly Investment Summary & Technical Buy Zone Confirmation - mfd.ru
What is Adverum Biotechnologies Inc.’s book value per shareJuly 2025 Outlook & Reliable Trade Execution Plans - mfd.ru
Decliners Report: Can Adverum Biotechnologies Inc beat the S P 500Sell Signal & Weekly High Conviction Ideas - baoquankhu1.vn
Eli Lilly To Acquire Adverum Biotechnologies - MSN
Bronstein, Gewirtz & Grossman, LLC Is Investigating Adverum Biote - The National Law Review
Can Adverum Biotechnologies Inc lead its sector in growthWeekly Trend Recap & Growth Focused Stock Reports - baoquankhu1.vn
Market Recap: How do insiders feel about Adverum Biotechnologies IncPortfolio Update Report & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Weekly Earnings: What is Adverum Biotechnologies Inc.’s book value per share2025 AllTime Highs & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Trade Report: Is ENTO a good stock for dollar cost averagingMarket Performance Summary & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Aug Intraday: Is Adverum Biotechnologies Inc showing insider buyingTrade Analysis Summary & Scalable Portfolio Growth Methods - baoquankhu1.vn
Insider Buy: What is the earnings history of Adverum Biotechnologies IncJuly 2025 Market Mood & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Aug EndMonth: Is Adverum Biotechnologies Inc a strong candidate for buy and holdEarnings Overview Summary & Scalable Portfolio Growth Methods - baoquankhu1.vn
$191.2 Million Achromatopsia Market Outlook, 2026-2032, - GlobeNewswire
$191.2 Million Achromatopsia Market Outlook, 2026-2032, Featuring Adverum Biotechnologies, Homology Medicines, Mattel, REGENXBIO, Sanofi and More - Yahoo Finance
Retail Surge: What is the earnings history of Adverum Biotechnologies IncJuly 2025 Selloffs & Daily Oversold Bounce Ideas - baoquankhu1.vn
Fund Flows: Can Adverum Biotechnologies Inc stock outperform in 2025 bull marketJuly 2025 EndofMonth & Long-Term Safe Return Strategies - Bộ Nội Vụ
Wall Street Recap: Why Adverum Biotechnologies Inc stock remains undervaluedQuarterly Growth Report & Verified Short-Term Plans - Bộ Nội Vụ
Gainers Report: Why Adverum Biotechnologies Inc stock remains undervaluedMarket Risk Report & Low Risk High Reward Trade Ideas - Bộ Nội Vụ
Is Adverum Biotechnologies Inc. stock a dividend growth opportunityJuly 2025 Update & Long-Term Capital Growth Ideas - Улправда
How Adverum Biotechnologies Inc. stock benefits from strong dollarPortfolio Return Report & Real-Time Stock Entry Alerts - Улправда
Why hedge funds are buying Adverum Biotechnologies Inc. stockJuly 2025 Closing Moves & Weekly Sector Rotation Insights - Улправда
What drives Adverum Biotechnologies Inc stock priceValue Stock Picks & Capital Planning and Optimization - earlytimes.in
ADVM stock touches 52-week low at $4.01 amid market challenges - MSN
Adverum Biotechnologies, Inc. Financial Disclosures & Filings - TradingView — Track All Markets
Adverum Biotechnologies (NASDAQ:ADVM) Stock Price Passes Above 50 Day Moving Average – Time to Sell? - Defense World
Is Adverum Biotechnologies Inc. (AVU0) stock trading at attractive multiplesJuly 2025 Catalysts & Short-Term High Return Ideas - Bölüm Sonu Canavarı
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Receives $10.50 Average PT from Brokerages - Defense World
What catalysts could drive Adverum Biotechnologies Inc. stock higherJuly 2025 Chart Watch & Fast Momentum Entry Tips - Улправда
Why Adverum Biotechnologies Inc. stock is rated strong buyWeekly Trend Report & Free Long-Term Investment Growth Plans - DonanımHaber
Why Adverum Biotechnologies Inc. stock is in analyst buy zoneJuly 2025 Market Mood & Reliable Breakout Stock Forecasts - DonanımHaber
Investor Mood: Why Adverum Biotechnologies Inc stock is in analyst buy zoneJuly 2025 Review & Precise Swing Trade Entry Alerts - moha.gov.vn
Adverum Biotechnologies releases promising phase 2 trial data - MSN
Adverum Biotechnologies Earnings Notes - Trefis
Adverum Biotechnologies, Inc. Stock ()Quote BOERSE BERLIN - marketscreener.com
Adverum Biotechnologies (NASDAQ:ADVM) Lowered to "Strong Sell" Rating by Wall Street Zen - MarketBeat
Adverum Biotechnologies (NASDAQ:ADVM) Lowered to “Strong Sell” Rating by Wall Street Zen - Defense World
Market Catalysts: Why hedge funds are buying Adverum Biotechnologies Inc stockJuly 2025 Spike Watch & Consistent Return Investment Signals - moha.gov.vn
Hedge Fund and Insider Trading News: Cathie Wood, Michael Burry, Renaissance Technologies, Mason Capital, Millennium Management, Adverum Biotechnologies Inc (ADVM), MGM Resorts International (MGM), and More - Insider Monkey
Adverum Biotechnologies, Inc.(NasdaqCM: ADVM) dropped from S&P TMI Index - marketscreener.com
Adverum Biotechnologies completes merger and delisting - MSN
Eli Lilly completes acquisition of Adverum Biotechnologies - MSN
CEO Fischer Acquires 650,000 Of Adverum Biotechnologies Inc [ADVM] - TradingView — Track All Markets
Lilly moves forward with $3.56-per-share acquisition of Adverum - Indian Pharma Post
Lilly completes tender offer for Adverum Biotechnologies By Investing.com - Investing.com Australia
Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition - The AI Journal
Lilly completes tender offer for Adverum Biotechnologies - Investing.com India
Eli Lilly (LLY) Stock on December 9, 2025: Jaypirca Breakthrough, Adverum Deal and Zepbound Price Cuts Reframe the Outlook - ts2.tech
Eli Lilly (LLY) Completes Acquisition of Adverum Biotechnologies - GuruFocus
Eli Lilly Moves Forward With Acquisition Of Adverum Biotechnologies - Nasdaq
Monday’s Insider Moves: Adverum Execs Lead Buys, Diamondback Sale Tops - Investing.com Australia
Adverum Biotechnologies Stock (ADVM) Opinions on Lilly Acquisition - Quiver Quantitative
Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition | Eli Lilly and Company - Eli Lilly
Lilly completes Adverum acquisition for $3.56 per share plus CVRs - StreetInsider
Laurent Fischer Acquires 117,614 Shares of Adverum Biotechnologies (NASDAQ:ADVM) Stock - MarketBeat
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):